Workflow
Analysts Reaffirm Buy Ratings on Amazon.com, Inc. (AMZN) with Price Targets up to $300
Yahoo Finance· 2025-12-18 06:14
Amazon.com Inc. (NASDAQ:AMZN) is one of billionaire David Tepper’s top stock picks heading into 2026. On December 10, TD Cowen’s John Blackledge kept a Buy rating on Amazon.com Inc. (NASDAQ:AMZN) with a $300 target. Two days earlier, on December 8, Roth MKM’s Rohit Kulkarni also reaffirmed a Buy, setting a $270 target. Analysts Reaffirm Buy Ratings on Amazon.com, Inc. (AMZN) with Price Targets up to $300 Zapp2Photo/Shutterstock.com On December 9, Amazon.com Inc. announced plans to invest $35 billion in ...
Susquehanna Touts Alibaba Group Holding Limited (BABA) Prospects on e-Commerce and Cloud Business Growth
Yahoo Finance· 2025-12-18 06:14
Alibaba Group Holding Limited (NYSE:BABA) is one of billionaire David Tepper’s top stock picks heading into 2026. On December 2, analysts at Susquehanna reiterated a Positive rating and a $190 price target on the stock. The bullish stance comes on the company announcing better-than-expected performance in its core China e-commerce business. Susquehanna Touts Alibaba Group Holding Limited (BABA) Prospects on e-Commerce and Cloud Business Growth Gil C / Shutterstock.com While revenue exceeded expectations ...
RBC Capital Bullish on ADC Therapeutics S.A. (ADCT) on Lymphoma Treatment Development
Yahoo Finance· 2025-12-18 06:14
ADC Therapeutics (NYSE:ADCT) is one of the best multibagger penny stocks to buy right now. On December 4, Guggenheim analyst Michael Schmidt reaffirmed his Buy rating on ADC Therapeutics (NYSE:ADCT) and set a price target of $10.00. On December 3, RBC Capital reiterated an Outperform rating and $5.00 price target in response to interim Phase Ib data from the LOTIS-7 trial. RBC Capital Bullish on ADC Therapeutics S.A. (ADCT) on Lymphoma Treatment Development Data from the LOTIS-7 trial evaluating the safe ...
Repay Holdings Corporation (RPAY) Focused on Market Expansion and Enhancing Technology Offerings
Insider Monkey· 2025-12-18 06:14
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...
American Bitcoin Corp (ABTC) Positioned for Long-term Value Creation as Bitcoin Treasury Grows
Yahoo Finance· 2025-12-18 06:14
American Bitcoin Corp (NASDAQ:ABTC) is one of the best multibagger penny stocks to buy right now. On December 10, Roth MKM analyst Darren Aftahi began coverage of American Bitcoin Corp (NASDAQ:ABTC) with a Buy rating and a $4.00 price target. American Bitcoin Corp (ABTC) Positioned for Long-term Value Creation as Bitcoin Treasury Grows On December 10, the company bolstered its Bitcoin holdings to 4,783 with the acquisition of 416 BTC coins. The accumulation includes Bitcoin acquired through mining operat ...
Absci Corporation (NASDAQ:ABSI)’s ABS‑201 Shows Promise in Hair Loss Treatment, Analysts See Upside
Yahoo Finance· 2025-12-18 06:14
Absci Corporation (NASDAQ:ABSI) is one of the best multibagger penny stocks to buy right now. On December 12, Needham’s Gil Blum reiterated a Buy rating on Absci Corporation (NASDAQ:ABSI) with a $7 price target, citing encouraging preclinical data for ABS‑201 in androgenetic alopecia and strong market interest ahead of the planned HEADLINE study. Earlier, on December 4, JonesTrading also maintained a Buy rating with a $9 target. Absci Corporation (NASDAQ:ABSI)’s ABS‑201 Shows Promise in Hair Loss Treatmen ...
Is Bit Digital, Inc. (BTBT) One of the Best Multibagger Penny Stocks to Buy Right Now?
Insider Monkey· 2025-12-18 06:14
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...
Hive Digital Technologies Ltd. (HIVE): Record Revenue, Global Listings, and Analyst Buy Ratings Drive Momentum
Yahoo Finance· 2025-12-18 06:14
HIVE Digital Technologies Ltd (NASDAQ:HIVE) is one of the best multibagger penny stocks to buy right now. On December 11, HIVE Digital Technologies Ltd (NASDAQ:HIVE) listed on the Colombian Stock Exchange, marking the first Bitcoin and AI infrastructure company to do so. The firm posted record quarterly revenue of $87.3 million, up 285% year‑over‑year, and is expanding its Paraguay operations with 25+ Exahash mining capacity, plans for 36,000 GPUs, and 400 MW of renewable energy. Already listed in Canada, ...
Northland Affirms Outperform Stance on Gevo, Inc. (GEVO) on Low-Carbon Renewable Fuels Prospects
Insider Monkey· 2025-12-18 06:14
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...
Clear Street Asserts Buy Rating on Annexon, Inc. (ANNX) amid Progress on Pipeline Development
Yahoo Finance· 2025-12-18 06:14
Annexon Inc. (NASDAQ:ANNX) is one of the best multibagger penny stocks to buy right now. On December 1, Clear Street initiated coverage of Annexon Inc. (NASDAQ:ANNX) with a Buy rating and a $17 price target. The positive stance is in response to the progress the company has made in developing complement inhibitors for inflammation-related diseases. Clear Street Asserts Buy Rating on Annexon, Inc. (ANNX) amid Progress on Pipeline Development Copyright: dolgachov / 123RF Stock Photo The company’s lead ass ...